Page last updated: 2024-09-02

ecteinascidin 743 and Dysplastic Nevus Syndrome, Hereditary

ecteinascidin 743 has been researched along with Dysplastic Nevus Syndrome, Hereditary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belotti, D; Borsotti, P; Carminati, L; D'Incalci, M; Giavazzi, R; Minoli, L; Pinessi, D; Taraboletti, G	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Dysplastic Nevus Syndrome, Hereditary

Article	Year
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma. Carcinogenesis, 2019, 04-29, Volume: 40, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Line, Tumor; Female; Macrophages; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Metastasis; NIH 3T3 Cells; Skin Neoplasms; Tissue Inhibitor of Metalloproteinase-1; Trabectedin; Tumor Microenvironment	2019

Article

Year

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.

Carcinogenesis, 2019, 04-29, Volume: 40, Issue:2

Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Line, Tumor; Female; Macrophages; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Metastasis; NIH 3T3 Cells; Skin Neoplasms; Tissue Inhibitor of Metalloproteinase-1; Trabectedin; Tumor Microenvironment

2019